Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain

Epilepsia

Volumn 46, Issue 6, 2005, Pages 849-857

  Aronica, Eleonora ^a,f   Gorter, Jan A ^b,c   Redeker, Sandra ^a   Van Vliet, Erwin A ^b,c   Ramkema, Marja ^a   Scheffer, George L ^d   Scheper, Rik J ^d   Van Der Valk, Paul ^d   Leenstra, Sieger ^a   Baayen, Johannes C ^d   Spliet, Wim G M ^e   Troost, Dirk ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Blood vessels; Endothelium; Epilepsy; Glioma; Glioneuronal tumors; Hippocampus

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 2;

ARTICLE; ASTROCYTE; ASTROCYTOMA; BRAIN MICROCIRCULATION; BRAIN TUMOR; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CORTICAL DYSPLASIA; DRUG BIOAVAILABILITY; EPILEPSY; GLIA CELL; GLIOBLASTOMA; HIPPOCAMPAL SCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTRACTABLE EPILEPSY; MICROVASCULATURE; NERVE CELL; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ASTROCYTOMA; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CEREBRAL CORTEX; ENDOTHELIUM, VASCULAR; EPILEPSIES, PARTIAL; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; OLIGODENDROGLIOMA; SCLEROSIS; TISSUE DISTRIBUTION;

EID: 20544436363     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2005.66604.x     Document Type: Article

References (37)

1. Sander JW. Some aspects of prognosis in the epilepsies: a review. Epilepsia 1993;34:1007-16.
2. Regesta G, Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res 1999;34:109-22.
3. Scheffer GL, Scheper RJ. Drug resistance molecules: lessons from oncology. Novartis Found Symp 2002;243:19-31;discussion 31-7.
4. Loscher W, Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 2002;301:7-14.
5. Sun H, Dai H, Shaik N, et al. Drug efflux transporters in the CNS. Adv Drug Deliv Rev 2003;55:83-105.
6. Sisodiya SM. Mechanisms of antiepileptic drug resistance. Curr Opin Neurol 2003;16:197-201.
7. Tishler DM, Weinberg KI, Hinton DR, et al. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 1995;36:1-6.
8. Sisodiya SM, Heffernan J, Squier MV. Over-expression of P-glycoprotein in malformations of cortical development. Neuroreport 1999;10:3437-41.
9. Dombrowski SM, Desai SY, Marroni M, et al. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 2001;42:1501-6.
10. Sisodiya SM, Lin WR, Harding MN, et al. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 2002;125:22-31.
11. Aronica E, Gorter JA, JansenGH, et al. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 2003;118:417-29.
12. Aronica E, Gorter JA, van Vliet EA, et al. Overexpression of the human major vault protein in gangliogliomas. Epilepsia 2003;44:1-10.
13. Aronica E, Gorter JA, Ramkema M, et al. Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia 2004;45:441-51.
14. Lazarowski A, Sevlever G, Taratuto A, et al. Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy. Pediatr Neurol 1999;21:731-4.
15. Litman T, Druley TE, Stein WD, et al. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 2001;58:931-59.
16. Lage H, Dietel M. Effect of the breast-cancer resistance protein on atypical multidrug resistance. Lancet Oncol 2000;1:169-75.
17. Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003;22:7340-58.
18. Bates SE, Robey R, Miyake K, et al. The role of half-transporters in multidrug resistance. J Bioenerg Biomembr 2001;33:503-11.
19. Maliepaard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001;61:3458-64.
20. Cooray HC, Blackmore CG, Maskell L, et al. Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 2002;13:2059-63.
21. Eisenblatter T, Huwel S, Galla HJ. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier. Brain Res 2003;971:221-31.
22. Cisternino S, Mercier C, Bourasset F, et al. Expression, upregulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res 2004;64:3296-301.
23. Kleihues P, Cavanee WK. World Health Organization classification of tumours. In: Kleihues P, Cavanee WK, eds. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000:10-69, 95-102.
24. Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology 2004;62(6 suppl 3):S2-8.
25. Scheffer GL, Schroeijers AB, Izquierdo MA, et al. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer. Curr Opin Oncol 2000;12:550-6.
26. Scheffer GL, Pijnenborg AC, Smit EF, et al. Multidrug resistance related molecules in human and murine lung. J Clin Pathol 2002;55:332-9.
27. Aronica E, Gorter JA, Jansen GH, et al. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 2003;118:417-29.
28. Kyin R, Hua Y, Baybis M, et al. Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex. Am J Pathol 2001;159:1541-54.
29. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
30. Hara A, Okayasu L. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol (Berl) 2004;108:43-8.
31. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid (published erratum appears in Anal Biochem 1987;163:279). Anal Biochem 1985;150:76-85.
32. Rosenow F, Luders HO, Dinner DS, et al. Histopathological correlates of epileptogenicity as expressed by electrocorticographic spiking and seizure frequency. Epilepsia 1998;39:850-6.
33. Aronica E, Leenstra S, van Veelen CW, et al. Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow-up of seizure outcome after surgery. Epilepsy Res 2001;43:179-91.
34. Blumcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 2002;61:575-84.
35. Crino PB, Miyata H, Vinters HV. Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol 2002;12:212-33.
36. Sisodiya SM, Martinian L, Scheffer GL, et al. Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy. Epilepsia 2003;44:1388-96.
37. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 2003;55:3-29.